rhinoplasty.cc
Menu

Journal archive · Anatomy and nasal analysis · 2019

APS Aesthetic Plastic Surgery · 2019

Clinical Application of Three-Dimensionally Printed Biomaterial Polycaprolactone (PCL) in Augmentation Rhinoplasty

Park YJ, Cha JH, Bang SI, Kim SY.

What this paper says

Across 101 patients receiving a 3D-printed dissolvable polycaprolactone mesh, 98.0 percent showed no infection or abnormal foreign body reaction, and biopsies at 20 months showed new cartilage-like tissue growing around the mesh.

Overview

Synthetic nasal implants carry infection and rejection risks, while the patient's own cartilage requires a harvest site. This study tested a third option: a 3D-printed mesh made from a material the body gradually breaks down, intended to act as a scaffold that tissue grows into.

Sections of note

  • Retrospective review of 101 patients receiving primary or secondary rhinoplasty with a polycaprolactone mesh.
  • Clinical efficacy and safety were evaluated with the Global Aesthetic Improvement Scale at 18 months after surgery.
  • 98.0 percent showed no postoperative infection-related foreign body reaction or distinct abnormal reaction.
  • Implants maintained long-term efficacy through the 18-month follow-up.
  • In patients who received spreader grafts, Cottle sign scores differed significantly between before and after surgery.
  • Biopsy specimens were obtained from two revision cases; histopathology at 20 months showed adjacent tissue infiltrating the mesh pores plus regeneration of new cartilage-like tissue and collagen around it.
  • The authors propose it as an alternative to non-absorbable materials for spreader and septal extension grafts. Level of evidence IV.

What it means for a patient

  • The mesh is designed to dissolve while tissue grows through it, so what remains is the patient's own tissue rather than a permanent implant.
  • Volume was maintained through 18 months, and tissue ingrowth was confirmed on biopsy in two cases.
  • Limits: 101 patients, retrospective, single center, no comparison group, and follow-up of 18 to 20 months.
  • Biopsy evidence comes from only two patients, both of whom needed revision.

Why this paper matters

Absorbable scaffolds would remove the trade-off between implant complications and donor site morbidity, and this reports both clinical and tissue-level findings. The histology showing new cartilage-like tissue is the notable part. Follow-up of under two years is short for judging whether volume holds once the scaffold has fully dissolved.

Terms

  • Polycaprolactone: A synthetic polymer that the body slowly breaks down.
  • Bioabsorbable scaffold: An implant designed to dissolve while tissue grows into its structure.
  • Foreign body reaction: The inflammation the body mounts against implanted material.
  • Histopathological analysis: Examination of tissue under a microscope.
  • Cottle sign: A bedside test where pulling the cheek outward reveals nasal valve collapse.

Summary written by rhinoplasty.cc from the abstract, 2026-09-09; not medical advice. The authors' own abstract follows.

From the abstract

“This clinical study aimed to investigate the safety and surgical outcome of three-dimensionally (3D) fabricated polycaprolactone (PCL) mesh in rhinoplasty. In particular, this study explored how a 3D-printed PCL mesh performs as a bioabsorbable scaffold after a long period following implantation. Methods: A…”

Excerpt; the full abstract is on PubMed.

Citation

PubMed
Journal
Aesthetic Plastic Surgery
Year
2019
Authors
4
Type
Journal Article
Access
Subscription
On this site
Summary and abstract

Start here

What the rhinoplasty literature says on this paper's topic, cited line by line to PubMed.

Related papers

Same topic, 2019.

  1. ASJ
    2019PMID 31145779
  2. ASJ
    2019PMID 30722008Summary
  3. ASJ
    2019PMID 29982464Summary
  4. APS
    2019PMID 30560283Summary
  5. APS
    2019PMID 30706084Summary
  6. APS
    2019PMID 30868305Summary
  7. FPS
    2019PMID 31470467
  8. JAMA FPS
    2019PMID 30489601Summary